BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.82 Million | 4.94 Million | 4.67 Million | 6.89 Million | 4.77 Million | 6.28 Million |
| Net Income | 6.46 Million | 5.45 Million | 6.28 Million | 3.79 Million | 4.36 Million | 5.7 Million |
| Depreciation & Amortization | 455.33 Thousand | 450.99 Thousand | 457.1 Thousand | 510.42 Thousand | 291.73 Thousand | 185.28 Thousand |
| Deferred income taxes | -133.96 Thousand | -8844.00 | -68.24 Thousand | -27.61 Thousand | 1.5 Million | 1.84 Million |
| Stock-based compensation | 513.48 Thousand | 439.67 Thousand | 334.41 Thousand | 266.17 Thousand | 263.24 Thousand | 390.38 Thousand |
| Change in working capital | -1.45 Million | -1.09 Million | -2.17 Million | 2.49 Million | -898.08 Thousand | -443.18 Thousand |
| Other non-cash items | -18.4 Thousand | -298.9 Thousand | -154.8 Thousand | -143.89 Thousand | -756.39 Thousand | -1.39 Million |
| Investing Cash Flow | 113.14 Thousand | -10.79 Million | -4.83 Million | 3.38 Million | -1.68 Million | -1.58 Million |
| Investments in PPE | -2.67 Million | -519.31 Thousand | -93.18 Thousand | -174.29 Thousand | -734.13 Thousand | -504.02 Thousand |
| Acquisitions | 2.5 Million | - | - | - | - | - |
| Investment purchases | -2.5 Million | -10.65 Million | -4.89 Million | - | -939.32 Thousand | -905.84 Thousand |
| Sales/Maturities of investments | 2.62 Million | - | - | 3.24 Million | - | - |
| Other Investing Activities | 158.76 Thousand | 383.9 Thousand | 146.45 Thousand | 317.29 Thousand | -11.53 Thousand | -175 Thousand |
| Financing Cash Flow | -5.78 Million | -4.37 Million | -2.07 Million | -3.37 Million | -6.38 Million | -505.26 Thousand |
| Debt repayment | -174.05 Thousand | -161.81 Thousand | -151.94 Thousand | -144.25 Thousand | -23.27 Thousand | - |
| Dividends payments | -1.91 Million | -483.95 Thousand | - | - | - | - |
| Common Stock Repurchased | -3.69 Million | -3.68 Million | -1.84 Million | -3.14 Million | -6.35 Million | -606.19 Thousand |
| Common Stock Issuance | 66.85 Thousand | 40.08 Thousand | 10.32 Thousand | 7415.00 | 4724.00 | 100.92 Thousand |
| Other Financing Activities | -68.41 Thousand | -77.14 Thousand | -74.92 Thousand | -85.52 Thousand | -11.53 Thousand | 100.92 Thousand |
| Accounts receivables | 241.36 Thousand | -426.37 Thousand | -1.26 Million | 650.55 Thousand | -352.98 Thousand | -32.09 Thousand |
| Accounts payables | 14.79 Thousand | 1.49 Million | -160.35 Thousand | 942.59 Thousand | 123.84 Thousand | 108.86 Thousand |
| Inventory | -1.48 Million | -2.43 Million | -130.77 Thousand | 65.56 Thousand | -655.73 Thousand | -574.56 Thousand |
| Other working capital | -225.3 Thousand | 271.13 Thousand | -620.8 Thousand | 835.29 Thousand | -13.21 Thousand | 54.6 Thousand |
| Cash at beginning of period | 5.29 Million | 18.03 Million | 20.29 Million | 13.44 Million | 16.83 Million | 12.65 Million |
| Cash at end of period | 4.9 Million | 7.86 Million | 18.03 Million | 20.29 Million | 13.44 Million | 16.83 Million |
| Capital Expenditure | -2.67 Million | -519.31 Thousand | -93.18 Thousand | -174.29 Thousand | -734.13 Thousand | -504.02 Thousand |
| Effect of forex changes on cash | -34.31 Thousand | 42.11 Thousand | -18.55 Thousand | -61.4 Thousand | -90.56 Thousand | -15.63 Thousand |
| Net cash flow / Change in cash | -392.3 Thousand | -10.17 Million | -2.25 Million | 6.84 Million | -3.39 Million | 4.18 Million |
| Free Cash Flow | 3.15 Million | 4.42 Million | 4.58 Million | 6.72 Million | 4.03 Million | 5.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.58 Million | 1.76 Million | 1.45 Million | 6.46 Million | 2.35 Million | 1.48 Million |
| Depreciation & Amortization | 121.79 Thousand | 114.98 Thousand | 121.35 Thousand | 455.33 Thousand | 111.94 Thousand | 111.63 Thousand |
| Deferred income taxes | 17.92 Thousand | 15.86 Thousand | -264.71 Thousand | -133.96 Thousand | -14.44 Thousand | -50.73 Thousand |
| Stock-based compensation | 137.97 Thousand | 123.51 Thousand | 136.63 Thousand | 513.48 Thousand | 134.16 Thousand | 124.67 Thousand |
| Change in working capital | -3.13 Million | -707.4 Thousand | -513.07 Thousand | -1.45 Million | -11.55 Thousand | 1.6 Million |
| Other non-cash items | 3.28 Million | 940.88 Thousand | -108.28 Thousand | -18.4 Thousand | -163.05 Thousand | -206.09 Thousand |
| Investing Cash Flow | 6.66 Million | -39.2 Thousand | -1.06 Million | 113.14 Thousand | -976.08 Thousand | 1.82 Million |
| Investments in PPE | -117.31 Thousand | -10.66 Thousand | -2.55 Million | -2.67 Million | -18.07 Thousand | -7786.00 |
| Acquisitions | - | - | - | 2.5 Million | - | - |
| Investment purchases | -4.29 Million | -1.6 Million | -2.5 Million | -2.5 Million | - | - |
| Sales/Maturities of investments | 11.01 Million | 1.57 Million | 1.42 Million | 2.62 Million | -1 Million | 1.2 Million |
| Other Investing Activities | 58.69 Thousand | - | 66.54 Thousand | 158.76 Thousand | 41.99 Thousand | 628.14 Thousand |
| Financing Cash Flow | -913.23 Thousand | -2.16 Million | -1.28 Million | -5.78 Million | -1.13 Million | -2.03 Million |
| Debt repayment | -45.6 Thousand | -45.02 Thousand | -44.22 Thousand | -174.05 Thousand | -43.64 Thousand | -43.27 Thousand |
| Dividends payments | -521.27 Thousand | -524.08 Thousand | -472.29 Thousand | -1.91 Million | -472.91 Thousand | -483.73 Thousand |
| Common Stock Repurchased | -369.36 Thousand | -1.57 Million | -821.36 Thousand | -3.69 Million | -604.35 Thousand | -1.48 Million |
| Common Stock Issuance | 38.02 Thousand | - | 66.85 Thousand | 66.85 Thousand | - | - |
| Other Financing Activities | -9411.00 | -270.19 Thousand | -16.39 Thousand | -68.41 Thousand | -16.96 Thousand | -17.34 Thousand |
| Accounts receivables | -3.22 Million | 695.03 Thousand | 610.13 Thousand | 241.36 Thousand | -108.38 Thousand | -11.72 Thousand |
| Accounts payables | 889.79 Thousand | -1.49 Million | -80.24 Thousand | 14.79 Thousand | 1.32 Million | 263.57 Thousand |
| Inventory | -310.67 Thousand | 175.61 Thousand | -1.33 Million | -1.48 Million | -466.04 Thousand | 488.12 Thousand |
| Other working capital | -482.36 Thousand | -83 Thousand | 287.91 Thousand | -225.3 Thousand | -762.54 Thousand | 867.7 Thousand |
| Cash at beginning of period | 4.96 Million | 4.9 Million | 6.08 Million | 5.29 Million | 9.29 Million | 6.41 Million |
| Cash at end of period | 9.3 Million | 4.96 Million | 4.9 Million | 4.9 Million | 9.66 Million | 9.29 Million |
| Capital Expenditure | -117.31 Thousand | -10.66 Thousand | -2.55 Million | -2.67 Million | -18.07 Thousand | -7786.00 |
| Effect of forex changes on cash | 314.00 | 178.00 | -152.08 Thousand | -34.31 Thousand | 73.08 Thousand | 14.47 Thousand |
| Net cash flow / Change in cash | 4.34 Million | 58.56 Thousand | -1.18 Million | -392.3 Thousand | 367.06 Thousand | 2.88 Million |
| Free Cash Flow | -1.13 Million | 1.26 Million | -1.72 Million | 3.15 Million | 2.38 Million | 3.06 Million |
EZE
TSLVF
IDR
PRM
CESC
ELA